EMILY GARDEL

Emily is currently patent counsel at Dyno Therapeutics, a biotech company in the gene therapy space using an AI platform to design AAV capsids, and enjoys developing an IP strategy and portfolio for an interdisciplinary company working at the cutting edge of both AAV capsid engineering and machine learning techniques. Prior to joining Dyno, Emily was in private practice for eight years, where her practice was focused on patent prosecution in areas where software and electronics overlap with biotechnology, including bioinformatics and machine learning technology.  Emily studied physics at Smith College before obtaining her PhD from Harvard and received her JD from Suffolk University Law School.